News | April 26, 2025
Zydus Lifesciences to acquire 85.6 % stake in Amplitude Surgical
The closing of the Block Acquisition is now expected to be completed by Q3 2025
The closing of the Block Acquisition is now expected to be completed by Q3 2025
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
This e-commerce platform is launched as a hyperlocal model
USFDA inspection at Emcure Pharmaceuticals API facility
Plans underway to expand screening capacity by 50% for greater accessibility
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Subscribe To Our Newsletter & Stay Updated
